Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Toronto

$59,183.00

A digital microfluidic platform for high yield CHO cell line detection and culture

FY 2021-22

Summary
In this NSERC Alliance proposal, Sartorius Canada, Sanofi Pasteur, and the Wheeler research group at the University of Toronto propose to work together to explore the development of digital microfluidic technologies for lead candidate identification and screening of therapeutic protein production from a model cell line (Chinese Hamster Ovary, or "CHO" cells). We are an ideal team to pursue this project, as Sartorius Canada is a market leader in the development of instrumentation that is used in the production of therapeutic proteins, Sanofi Pasteur is one of the top vaccine-producers in the world, and the Wheeler group has a long track record in automating cell culture and analysis using the unique platform that is known as digital microfluidics (DMF). We propose to develop new DMF-enabled systems that allow for the optimization of CHO cell production of monoclonal antibodies, recombinant vaccine proteins, and other important bioproducts. The key deliverable of this work is a platform that could eventually serve as the basis for a Sartorius product that will allow end-users such as Sanofi Pasteur to automate CHO cell culture to identify high-performing cells and/or optimal media formulations which lead to the highest protein yield, which will increase efficiency and profitability. This application represents the beginning of what may eventually become an important Canadian story - the development of digital microfluidic systems for efficient protein production in CHO cells. We thank NSERC in advance for potential support of this nascent effort, which could lead to important benefits for Canadians and others around the world.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
559533-2020
Name nom
Wheeler, Aaron
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2020
Award amount
59183
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:2
Partie
1
Nb partie
2
Application title
A digital microfluidic platform for high yield CHO cell line detection and culture
Keyword
NSERC
Application summary
In this NSERC Alliance proposal, Sartorius Canada, Sanofi Pasteur, and the Wheeler research group at the University of Toronto propose to work together to explore the development of digital microfluidic technologies for lead candidate identification and screening of therapeutic protein production from a model cell line (Chinese Hamster Ovary, or "CHO" cells). We are an ideal team to pursue this project, as Sartorius Canada is a market leader in the development of instrumentation that is used in the production of therapeutic proteins, Sanofi Pasteur is one of the top vaccine-producers in the world, and the Wheeler group has a long track record in automating cell culture and analysis using the unique platform that is known as digital microfluidics (DMF). We propose to develop new DMF-enabled systems that allow for the optimization of CHO cell production of monoclonal antibodies, recombinant vaccine proteins, and other important bioproducts. The key deliverable of this work is a platform that could eventually serve as the basis for a Sartorius product that will allow end-users such as Sanofi Pasteur to automate CHO cell culture to identify high-performing cells and/or optimal media formulations which lead to the highest protein yield, which will increase efficiency and profitability. This application represents the beginning of what may eventually become an important Canadian story - the development of digital microfluidic systems for efficient protein production in CHO cells. We thank NSERC in advance for potential support of this nascent effort, which could lead to important benefits for Canadians and others around the world.